ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,171.12
0.61%
Dow Jones
39,308.00
-0.06%
Gold vs US Dollar
2,357.425
1.17%
Brent Oil
86.91
0.54%
Bitcoin
60,262.28
-2.84%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pharmaceutical Prod Dev (MM) (PPDI)

  7. Pharmaceutical Prod Dev (MM) (PPDI) News

Pharmaceutical Product Developme (PPDI)

Pharmaceutical Prod Dev (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PPDI
DateTimeSourceHeadlineSymbolCompany
07/12/202114:00Business WirePPD Named to ‘Best Workplaces in Greater China’ for Second Consecutive YearNASDAQ:PPDIPharmaceutical Prod Dev (MM)
02/12/202114:00Business WirePPD Named ‘Best Vaccine CRO of the Year’ in Asia-PacificNASDAQ:PPDIPharmaceutical Prod Dev (MM)
22/11/202114:00Business WirePPD Wins Multiple Awards at Clinical Researcher of the Year CompetitionNASDAQ:PPDIPharmaceutical Prod Dev (MM)
27/10/202121:10Business WirePPD Reports Third Quarter and Year-To-Date 2021 ResultsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
19/10/202114:00Business WirePPD Named Clinical Research Company of the Year for Second Consecutive YearNASDAQ:PPDIPharmaceutical Prod Dev (MM)
18/10/202121:05Business WirePPD Announces Third Quarter 2021 Earnings Conference CallNASDAQ:PPDIPharmaceutical Prod Dev (MM)
06/10/202114:00Business WireSociety for Clinical Research Sites Names PPD Winner of Prestigious Eagle AwardNASDAQ:PPDIPharmaceutical Prod Dev (MM)
21/09/202114:00Business WirePPD Earns Gold Award for Excellence in Employee Learning and DevelopmentNASDAQ:PPDIPharmaceutical Prod Dev (MM)
01/09/202114:00Business WirePPD Receives Award Recognizing Employee Talent DevelopmentNASDAQ:PPDIPharmaceutical Prod Dev (MM)
28/07/202121:11Business WirePPD Reports Second Quarter and Year-To-Date 2021 ResultsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
20/07/202114:00Business WirePPD Recognized as a Best Place to Work in AsiaNASDAQ:PPDIPharmaceutical Prod Dev (MM)
12/07/202121:10Business WirePPD Announces Second Quarter 2021 Earnings Conference CallNASDAQ:PPDIPharmaceutical Prod Dev (MM)
27/05/202114:00Business WirePPD Named ‘Most Innovative CRO’ by Triangle Business JournalNASDAQ:PPDIPharmaceutical Prod Dev (MM)
24/05/202114:00Business WirePPD Opens Multipurpose Clinical Research Laboratory in Suzhou, ChinaNASDAQ:PPDIPharmaceutical Prod Dev (MM)
21/05/202102:00Business WirePPD百时益位于苏州的多功能临床研究实验室正式投入运营NASDAQ:PPDIPharmaceutical Prod Dev (MM)
21/05/202102:00Business WirePPD百時益位於蘇州的多功能臨床研究實驗室正式投入運營NASDAQ:PPDIPharmaceutical Prod Dev (MM)
20/05/202114:00Business WireCRO Leadership Awards Recognize PPD for Excellence for 10th Consecutive YearNASDAQ:PPDIPharmaceutical Prod Dev (MM)
06/05/202113:30Business WirePPD Named “Best CRO” at Vaccine Industry Excellence AwardsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
28/04/202114:00Business WirePPD to Expand GMP Lab in Ireland to Enhance Biopharmaceutical Testing CapabilitiesNASDAQ:PPDIPharmaceutical Prod Dev (MM)
27/04/202121:13Business WirePPD Reports First Quarter 2021 ResultsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
27/04/202114:00Business WirePPD and Science 37® Strengthen Collaboration to Advance Decentralized Clinical Trials and Accelerate DevelopmentNASDAQ:PPDIPharmaceutical Prod Dev (MM)
07/04/202114:00Business WirePPD Announces First Quarter 2021 Earnings Conference CallNASDAQ:PPDIPharmaceutical Prod Dev (MM)
24/03/202113:00Business WirePPD and Clinical Ink Collaborate on Innovative Process for Lupus Assessment and Near Real-Time Access to Endpoint DataNASDAQ:PPDIPharmaceutical Prod Dev (MM)
17/03/202113:27Business Wire PPD Named a Leader in Digital Clinical Trial Solutions by ISGNASDAQ:PPDIPharmaceutical Prod Dev (MM)
26/02/202115:00Business WirePPD Lights Up Headquarters Downtown for 2021 Rare Disease DayNASDAQ:PPDIPharmaceutical Prod Dev (MM)
24/02/202112:00Business WirePPD to Present at Barclays Global Healthcare ConferenceNASDAQ:PPDIPharmaceutical Prod Dev (MM)
23/02/202121:05Business WirePPD Reports Fourth Quarter and Full Year 2020 ResultsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
18/02/202114:00Business WirePPD Awarded US Army Study to Help Develop Post-Traumatic Stress Disorder DrugsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
17/02/202115:00Business WirePPD Honored for Employee Development Programs that Deliver Results for CustomersNASDAQ:PPDIPharmaceutical Prod Dev (MM)
03/02/202122:10Business WirePPD Announces Fourth Quarter and Full-Year 2020 Earnings Conference CallNASDAQ:PPDIPharmaceutical Prod Dev (MM)
 Showing the most relevant articles for your search:NASDAQ:PPDI

Your Recent History

BIT
F18813
Vontobel Financial Produ...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved